Leyla received her Bachelor's degree in Neuroscience from Pomona College in 2018. She is a PhD candidate in Professor Li-Huei Tsai's lab in MIT's Department of Brain and Cognitive Sciences.

Elissavet is a graduate of Biology at the Aristotle University of Thessaloniki and holds an MSc in Molecular Biomedicine from the National and Kapodistrian University of Athens , specializing in neuroscience. She is currently working towards her Ph.D. at the Hellenic Pasteur Institute and her research is mainly focused on the mechanisms of p.A53T-αSyn mediated synaptic dysfunction. Specifically, by exploiting a transgenic mouse and hiPSC-derived neurons bearing the p.A53T-αSyn mutation, she investigates for the first time the possible link between the dysregulation of three post-synaptic molecules that belong to the SLITRK family and αSyn.

In 2000 I completed the B.Sc. in Microbiology with grade of 82% (Ranked 1st out of 168 students) from Al-Mustansiriyah University. In 2005, I completed my degree in M.Sc. Genetic Engineering and Biotechnology with grade of 79% from Baghdad University. I got an award of NUORS (Newcastle University Overseas Research Scholarship) 2018/2019. I have started my PhD study (fulltime) in Neurosciences Medical School / Newcastle University in January 2020. My project in alpha-synucleinopathies neurodegenerative diseases.

I'm a clinical scientist at Roche. I got my Ph.D. neuroscience in 2015 in Bordeaux, France. I then moved to Basel, Switzerland in 2016 to realize a post-doc on the neural basis of motor circuits. After two years, I decided to move to the pharma industry, and started as a CRA in a start-up, Firalis, based in Huningue, France. I was involved in the development of an in-vitro diagnostic tool for Alzheimer's disease. I finally moved in 2020 at Roche, in Basel, in a clinical scientist role, where I'm involved in different clinical projects for Alzheimer's disease.

Panos is Lecturer Registrar at the Global Brain Health Institite (GBHI) at Trinity College Dublin, Ireland, Associate Professor of Psychiatry-Psychogeriatrics at the University of Patras, Greece, and Adjunct Professor of Psychiatry and Psychotherapy at Technical University of Munich, Germany. His research focus encompasses early diagnosis and markers of Alzheimer’s disease, geriatric depression, age-related sensory loss, as well as issues of philosophy and mental health.

doctor genetica

Alicia Algeciras-Schimnich, Ph.D., is a Consultant of the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, where she holds the academic rank of Professor of Laboratory Medicine and Pathology. She is Director of the Clinical Immunoassay Laboratory. Dr. Algeciras-Schimnich has published more than 100 peer-reviewed articles, abstracts, and book chapters. She serves as principal investigator of a number of industry-sponsored studies at Mayo Clinic. Her research interests focus on Alzheimer’s disease biomarkers, neurodegeneration markers, tumor markers, and multianalyte assays with algorithm analysis (MAAA) in clinical diagnosis.

My research is focused to decipher the underlying cellular and molecular mechanism to identifying novel/potential biomarkers and therapeutic targets and developing translation/clinical therapeutics for the treatment of incurable protein misfolded neurodegenerative diseases such as Alzheimer's disease and prion diseases. Over my career, I have authored 41 (17 as a principal & 24 as a co-author) peer-reviewed articles in high-quality journals, one editorial, four special issues, and one E-Book, and presented my work at over 18 seminars/conferences. My work has been cited 3000 times, receiving an h-index of 26 and an i10-index of 34.

Final year PhD student in the Parson Lab at the University of Aberdeen. Our research interests are understanding non-neuronal manifestations of the paediatric motor neuron disease, Spinal Muscular Atrophy (SMA). In particular, my research focuses on vascular pathology in SMA and its potential impact on the neuronal environment.

I am a PhD student at the School of Medicine, University of Minho in Braga and a neuroradiology resident at Centro Hospital Universitário do Porto. I am interested in how MRI can be used to enquire about the microstructure of the brain and, in particular, how it can help elucidate the pathophysiology of Alzheimer's disease. Through my years of clinical practice in contact with patients, I grew aware of the impact of psychosis in caregivers and patients with Alzheimer's disease. The realization that these symptoms can be so distressing and difficult to treat, so disruptive of the normal functioning of the brain, led the way for my curiosity and will to help clarify their underlying mechanisms. Combining MRI, neuropathology and cognitive assessments, I have dedicated part of my PhD to the study of psychotic symptoms in Alzheimer's.